TRIAL PHASE 1/2 Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD-001) in Patients with Severe Sickle Cell Disease VIEW CLINICAL TRIAL OVERVIEW